Ledger.Open graph →
SEC Form D · filed November 24, 2025

Jaguar Health, Inc

Offering
$10.8M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Anula Jayasuriya · San Francisco, CADirectorLisa Conte · San Francisco, CAExec · DirectorJohn Micek Iii · San Francisco, CADirectorJonathan Siegel · San Francisco, CADirectorCarol Lizak · San Francisco, CAExecSteven King · San Francisco, CAExecJames Bochnowski · San Francisco, CADirectorJonathan Wolin · San Francisco, CAExecPravin Chaturvedi · San Francisco, CAExecSteven King · San Francisco, CAExecJonathan Siegel · San Francisco, CADirectorCarol Lizak · San Francisco, CAExecAnula Jayasuriya · San Francisco, CADirectorLisa Conte · San Francisco, CAExec · DirectorJonathan Wolin · San Francisco, CAExecJohn Micek Iii · San Francisco, CADirectorPravin Chaturvedi · San Francisco, CAExecJames Bochnowski · San Francisco, CADirectorKelly Dulong · Seattle, WADirectorAlan Okagaki · Seattle, WAExecNorma Hernandez · Seattle, WAExecAman Jeloka · Seattle, WADirectorSue Taoka · Seattle, WAExec · DirectorMary Houghton · Seattle, WADirectorLee Winslett · Seattle, WADirectorGregory Bradley · Seattle, WAExecBruce Brooks · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗